Nemorubicin is a doxorubicin derivative with potent antitumor activity, effective against multidrug-resistant tumor cell lines. It intercalates into duplex DNA and stabilizes G-quadruplex structures. Unlike its parent compound, nemorubicin requires an intact nucleotide excision repair (NER) system for cytotoxicity and exhibits a distinct spectrum of antitumor activity.
Usually ships within 24 hours.